Microbiome-based assays for CRC detection take advantage of the differences in bacterial species, viruses, fungi, and microbiome-generated metabolites between stool from CRC/AA-associated and health-associated microbiomes to develop biomarkers that can be used for CRC or AA detection, either independently or along with established tests such as FOBT, FIT, or MT-sDNA.